Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabrielle Macaron

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Vaccines|December 30, 2020
Safety of Newer Disease Modifying Therapies in Multiple SclerosisGeorges Jalkh, Rachelle Abi Nahed, Gabrielle Macaron, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2018
Genetic findings in adolescent and adult-onset leukodystrophies with hypomyelinating featuresGabrielle Macaron, Simon Samaan, Jeffrey A Cohen, et al.
Patient Preference and Adherence|May 31, 2022
Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and AdherenceSajida Sabsabi, Elio Mikhael, Georges Jalkh, et al.
International Journal of MS Care|May 20, 2024
Association Between Disease-Modifying Therapy and Information Processing Speed in Multiple SclerosisAlbert Aboseif, Moein Amin, James Bena, et al.
Multiple Sclerosis and Related Disorders|July 4, 2021
Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting?Rachel Galioto, Gabrielle Macaron, John W Lace, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2023
High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challengeChadi Azar, Grace Akiki, Sara F Haddad, et al.
Parkinsonism & Related Disorders|May 22, 2019
Defining the spectrum of spasticity-associated involuntary movementsHesham Abboud, Gabrielle Macaron, Xin Xin Yu, et al.
Frontiers in Neurology|July 24, 2023
Impact of aging on treatment considerations for multiple sclerosis patientsGabrielle Macaron, Catherine Larochelle, Nathalie Arbour, et al.
Community Mental Health Journal|December 17, 2013
Anxiety, depression and suicidal ideation in Lebanese patients undergoing hemodialysisGabrielle Macaron, Mario Fahed, Dany Matar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica spectrum disorderGabrielle Macaron, Jean Khoury, James Bena, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Vaccines|December 30, 2020
Safety of Newer Disease Modifying Therapies in Multiple SclerosisGeorges Jalkh, Rachelle Abi Nahed, Gabrielle Macaron, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2018
Genetic findings in adolescent and adult-onset leukodystrophies with hypomyelinating featuresGabrielle Macaron, Simon Samaan, Jeffrey A Cohen, et al.
Patient Preference and Adherence|May 31, 2022
Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and AdherenceSajida Sabsabi, Elio Mikhael, Georges Jalkh, et al.
International Journal of MS Care|May 20, 2024
Association Between Disease-Modifying Therapy and Information Processing Speed in Multiple SclerosisAlbert Aboseif, Moein Amin, James Bena, et al.
Multiple Sclerosis and Related Disorders|July 4, 2021
Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting?Rachel Galioto, Gabrielle Macaron, John W Lace, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2023
High fever in myelin oligodendrocyte glycoprotein-associated disorder (MOGAD): A diagnostic challengeChadi Azar, Grace Akiki, Sara F Haddad, et al.
Parkinsonism & Related Disorders|May 22, 2019
Defining the spectrum of spasticity-associated involuntary movementsHesham Abboud, Gabrielle Macaron, Xin Xin Yu, et al.
Frontiers in Neurology|July 24, 2023
Impact of aging on treatment considerations for multiple sclerosis patientsGabrielle Macaron, Catherine Larochelle, Nathalie Arbour, et al.
Community Mental Health Journal|December 17, 2013
Anxiety, depression and suicidal ideation in Lebanese patients undergoing hemodialysisGabrielle Macaron, Mario Fahed, Dany Matar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica spectrum disorderGabrielle Macaron, Jean Khoury, James Bena, et al.
Pageof 4